These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 28856290)
1. Recommendations for the treatment of hepatitis C in 2017. ; Halota W; Flisiak R; Juszczyk J; Małkowski P; Pawłowska M; Simon K; Tomasiewicz K Clin Exp Hepatol; 2017 Jun; 3(2):47-55. PubMed ID: 28856290 [TBL] [Abstract][Full Text] [Related]
2. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus: A time for decisions. Who should be treated and when? Attar BM; Van Thiel DH World J Gastrointest Pharmacol Ther; 2016 Feb; 7(1):33-40. PubMed ID: 26855810 [TBL] [Abstract][Full Text] [Related]
4. Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study. Janczewska E; Kołek MF; Lorenc B; Klapaczyński J; Tudrujek-Zdunek M; Sitko M; Mazur W; Zarębska-Michaluk D; Buczyńska I; Dybowska D; Czauż-Andrzejuk A; Berak H; Krygier R; Jaroszewicz J; Citko J; Piekarska A; Dobracka B; Socha Ł; Deroń Z; Laurans Ł; Białkowska-Warzecha J; Tronina O; Adamek B; Tomasiewicz K; Simon K; Pawłowska M; Halota W; Flisiak R World J Gastroenterol; 2021 May; 27(18):2177-2192. PubMed ID: 34025072 [TBL] [Abstract][Full Text] [Related]
5. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade. Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250 [TBL] [Abstract][Full Text] [Related]
6. Recommendations for the treatment of hepatitis B in 2017. ; Flisiak R; Halota W; Jaroszewicz J; Juszczyk J; Małkowski P; Pawłowska M; Piekarska A; Simon K; Tomasiewicz K; Wawrzynowicz-Syczewska M Clin Exp Hepatol; 2017 Jun; 3(2):35-46. PubMed ID: 28856289 [TBL] [Abstract][Full Text] [Related]
7. Advances in the treatment of hepatitis C. Lawrence SP Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046 [TBL] [Abstract][Full Text] [Related]
8. [Evaluation of viral hepatitis in solid organ transplantation]. Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153 [TBL] [Abstract][Full Text] [Related]
9. Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection. Salama II; Raslan HM; Abdel-Latif GA; Salama SI; Sami SM; Shaaban FA; Abdelmohsen AM; Fouad WA World J Hepatol; 2022 Jun; 14(6):1053-1073. PubMed ID: 35978668 [TBL] [Abstract][Full Text] [Related]
10. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses. Abruzzi A; Fried B; Alikhan SB Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949 [TBL] [Abstract][Full Text] [Related]
11. From current status to optimization of HCV treatment: Recommendations from an expert panel. Craxì A; Perno CF; Viganò M; Ceccherini-Silberstein F; Petta S; Dig Liver Dis; 2016 Sep; 48(9):995-1005. PubMed ID: 27388261 [TBL] [Abstract][Full Text] [Related]
12. Antiviral therapies for chronic hepatitis C virus infection with cirrhosis. Nakamoto S; Kanda T; Shirasawa H; Yokosuka O World J Hepatol; 2015 May; 7(8):1133-41. PubMed ID: 26052402 [TBL] [Abstract][Full Text] [Related]
13. Recent advances in the treatment of hepatitis C virus infection for special populations and remaining problems. Suda G; Sakamoto N J Gastroenterol Hepatol; 2021 May; 36(5):1152-1158. PubMed ID: 32667068 [TBL] [Abstract][Full Text] [Related]
14. Successful Eradication of Hepatitis C Virus by Interferon-Free Regimens in Two Patients with Advanced Liver Fibrosis following Kidney Transplantation. Sasaki R; Kanda T; Yasui S; Haga Y; Nakamura M; Yamato M; Wu S; Nakamoto S; Arai M; Mikami S; Miyauchi H; Matsubara H; Yokosuka O Case Rep Gastroenterol; 2016; 10(2):248-56. PubMed ID: 27462193 [TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic hepatitis C in Asia: when East meets West. Yu ML; Chuang WL J Gastroenterol Hepatol; 2009 Mar; 24(3):336-45. PubMed ID: 19335784 [TBL] [Abstract][Full Text] [Related]
16. Treatment of hepatitis C: a systematic review. Kohli A; Shaffer A; Sherman A; Kottilil S JAMA; 2014 Aug; 312(6):631-40. PubMed ID: 25117132 [TBL] [Abstract][Full Text] [Related]
17. Management of chronic viral hepatitis before and after renal transplantation. Gane E; Pilmore H Transplantation; 2002 Aug; 74(4):427-37. PubMed ID: 12352899 [TBL] [Abstract][Full Text] [Related]
18. Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020. Halota W; Flisiak R; Juszczyk J; Małkowski P; Pawłowska M; Simon K; Tomasiewicz K Clin Exp Hepatol; 2020 Sep; 6(3):163-169. PubMed ID: 33145422 [TBL] [Abstract][Full Text] [Related]
19. Reversion of disease manifestations after HCV eradication. van der Meer AJ; Berenguer M J Hepatol; 2016 Oct; 65(1 Suppl):S95-S108. PubMed ID: 27641991 [TBL] [Abstract][Full Text] [Related]
20. NIH consensus development statement on management of hepatitis B. Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]